Princeton Global Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Princeton Global Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$13.2K	–	658
2024 Q4	$13.2K	Hold	1,000	–	–	﹤0.01%	463
2024 Q3	$14.2K	Hold	1,000	–	–	﹤0.01%	459
2024 Q2	$12.9K	Hold	1,000	–	–	﹤0.01%	434
2024 Q1	$13.9K	Hold	1,000	–	–	﹤0.01%	401
2023 Q4	$14.3K	Buy	+1,000	New	+$14.2K	﹤0.01%	404

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Princeton Global Asset Management's TAK Position: Q1 2025 in Review

Princeton Global Asset Management sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 1,000 shares — an estimated $13.2K sold.

Princeton Global Asset Management first reported a position in TAK in Q4 2023 and held it in 5 quarters. The position peaked at $14.3K in Q4 2023. 307 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

Princeton Global Asset Management reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Princeton Global Asset Management sold 1,000 Takeda Pharmaceutical shares in Q1 2025, an estimated $13.2K.
Princeton Global Asset Management first reported a position in Takeda Pharmaceutical in Q4 2023 and held it in 5 quarters.
Princeton Global Asset Management's Takeda Pharmaceutical position peaked at $14.3K in Q4 2023.
307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Princeton Global Asset Management's 13F filing for Q1 2025, filed 11 Apr 2025.